IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)
MD Anderson Cancer Center Madrid – Hospiten and emov join forces to build awareness among the public in Madrid of the effects of airborne pollution on the health Published on 15/11/2018 Published November 15 2018